Biopharmaceutical Production Technology, 2 Volume Set

UPSTREAM TECHNOLOGIES
Strategies for Plasmid DNA Production in Escherichia coli
Advances in Protein Production Technologies
PROTEIN RECOVERY
Releasing Biopharmaceutical Products from Cells
Continuous Chromatography (Multicolumn Countercurrent Solvent Gradient Purification) for Protein Purification
Virus-Like Particle Bioprocessing
Therapeutic Protein Stability and Formulation
Production of PEGylated Proteins
ADVANCES IN PROCESS DEVELOPMENT
Affinity Chromatography: Historical and Prospective Overview
Hydroxyapatite in Bioprocessing
Monoliths in Bioprocessing
Membrane Chromatography for Biopharmaceutical Manufacturing
Modeling and Experimental Model Parameter Determination with Quality by Design for Bioprocesses
ANALYTICAL TECHNOLOGIES
Biosensors in the Processing and Analysis of Biopharmaceuticals
Proteomics Toolkit: Applications in Protein Biological Production and Method Development
Science of Proteomics: Historical Perspectives and Possible Role in Human Healthcare
QUALITY CONTROL
Consistency of Scale-Up from Bioprocess Development to Production
Systematic Approach to Optimization and Comparability of Biopharmaceutical Glycosylation Throughout the Drug Life Cycle
Quality and Risk Management in Ensuring the Virus Safety of Biopharmaceuticals
Ensuring Quality and Efficiency of Bioprocesses by the Tailored Application of Process Analytical Technology and Quality by Design
PROCESS DESIGN AND MANAGEMENT
Bioprocess Design and Production Technology for the Future
Integrated Process Design: Characterization of Process and Product Definition of Design Spaces
Evaluating and Visualizing the Cost-Effectiveness and Robustness of Biopharmaceutical Manufacturing Strategies
CHANGING FACE OF PROCESSING
Full Plastics: Consequent Evolution in Pharmaceutical Biomanufacturing from Vial to Warehouse
BioSMB Technology: Continuous Countercurrent Chromatography Enabling a Fully Disposable Process
Single-Use Technology: Opportunities in Biopharmaceutical Processes
Single-Use Biotechnologies and Modular Manufacturing Environments Invite Paradigm Shifts in Bioprocess Development and Biopharmaceutical Manufacturing